
Chemical and Pharmaceutical Bulletin p. 184 - 193 (2000)
Update date:2022-09-26
Topics:
Okada, Yoshio
Matsumoto, Yoshikazu
Tsuda, Yuko
Tada, Mayako
Wanaka, Keiko
Hijikata-Okunomiya, Akiko
Okamoto, Shosuke
Various compounds were synthesized by combining three components at positions P1, P1, and P2,. Of these, N-(trans-4- aminomethylcyclohexanecarbonyl)-Tyr(O-2-bromobenzyloxycarbonyl)-octylamide inhibited plasmin selectively with IC50 values of 0.80 and 0.23 μM towards S-2251 and fibrin, respectively. This compound also inhibited plasma kallikrein, urokinase, thrombin and trypsin with IC50 values of 10, >50, >50 and 1.6 μM, respectively.
View MoreShanDong XinDa Chemical CO.,LTD(expird)
Contact:086-0311-87580543
Address:No.168, High Technology Development Zone Jinan Shandong China
Contact:86+21-56421993
Address:3F,BUILDING 10,NO.2889 JINKE ROAD, SHANGHAI.
Suzhou CarbonWell Pharma-Tech Co., Ltd
Contact:Tel: + 86 (0)512-8898-1216; + 86-18606258602
Address:2358 Changan Road, Wujiang Scientific Innovation Park, Wujiang, Jiangsu Province, P. R. China 215200
ZiBO KuoDing Trade company Ltd
website:http://www.sdzbkd.com
Contact:86-13361591822
Address:GongQingTuan road
Luojiang Chenming Biological Products Co
Contact:+86 15000297032
Address:GROUP NO.4, HE SHENG VILLAGE, PANLONG TOWN,
Doi:10.1021/ja01349a029
(1932)Doi:10.1080/00397910008087117
(2000)Doi:10.1021/jo00803a026
(1971)Doi:10.1016/j.tetasy.2016.11.007
(2017)Doi:10.1016/j.poly.2012.06.079
(2013)Doi:10.1021/om400130m
(2013)